Evidence map›Paper›PMID 28348956›Full record

ArticleNeuroImage. Clinical2017

High-dose antidepressants affect near-infrared spectroscopy signals: A retrospective study.

Akihiro Takamiya, Jinichi Hirano, Yuki Ebuchi, Satoyuki Ogino, Kenichi Shimegi, Hiroyuki Emura, Kyoko Yonemori, Akiko Shimazawa, Gentaro Miura, Ayako Hyodo and 7 more

Open access · goldAbstract read
In one paragraph

Article in NeuroImage. Clinical, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed, 1 pooled it
2.6field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 1 synthesis or guideline pooled it, 52 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Article
  6. Observational
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 1 institution in 1 country.

Akihiro TakamiyaDepartment of Neuropsychiatry, Keio University School of Medicine, 35, Shinanomachi, Shinjuku-ku, Tokyo 160-8582, Japan.
Jinichi HiranoDepartment of Neuropsychiatry, Keio University School of Medicine, 35, Shinanomachi, Shinjuku-ku, Tokyo 160-8582, Japan.
Yuki EbuchiDepartment of Neuropsychiatry, Keio University School of Medicine, 35, Shinanomachi, Shinjuku-ku, Tokyo 160-8582, Japan.
Satoyuki OginoDepartment of Neuropsychiatry, Keio University School of Medicine, 35, Shinanomachi, Shinjuku-ku, Tokyo 160-8582, Japan.
Kenichi ShimegiDepartment of Neuropsychiatry, Keio University School of Medicine, 35, Shinanomachi, Shinjuku-ku, Tokyo 160-8582, Japan.
Hiroyuki EmuraDepartment of Neuropsychiatry, Keio University School of Medicine, 35, Shinanomachi, Shinjuku-ku, Tokyo 160-8582, Japan.
Kyoko YonemoriDepartment of Neuropsychiatry, Keio University School of Medicine, 35, Shinanomachi, Shinjuku-ku, Tokyo 160-8582, Japan.
Akiko ShimazawaDepartment of Neuropsychiatry, Keio University School of Medicine, 35, Shinanomachi, Shinjuku-ku, Tokyo 160-8582, Japan.
Gentaro MiuraDepartment of Neuropsychiatry, Keio University School of Medicine, 35, Shinanomachi, Shinjuku-ku, Tokyo 160-8582, Japan.
Ayako HyodoDepartment of Neuropsychiatry, Keio University School of Medicine, 35, Shinanomachi, Shinjuku-ku, Tokyo 160-8582, Japan.
Sari HyodoDepartment of Neuropsychiatry, Keio University School of Medicine, 35, Shinanomachi, Shinjuku-ku, Tokyo 160-8582, Japan.
Tunetaka NagaiDepartment of Neuropsychiatry, Keio University School of Medicine, 35, Shinanomachi, Shinjuku-ku, Tokyo 160-8582, Japan.
Madoka FunakiDepartment of Neuropsychiatry, Keio University School of Medicine, 35, Shinanomachi, Shinjuku-ku, Tokyo 160-8582, Japan.
Masako SugiharaDepartment of Neuropsychiatry, Keio University School of Medicine, 35, Shinanomachi, Shinjuku-ku, Tokyo 160-8582, Japan.
Mitsuhiro KitaBrain Energy, 1-28-5, Komaba, Meguro-ku, Tokyo 153-0041, Japan.
Bun YamagataDepartment of Neuropsychiatry, Keio University School of Medicine, 35, Shinanomachi, Shinjuku-ku, Tokyo 160-8582, Japan.
Masaru MimuraDepartment of Neuropsychiatry, Keio University School of Medicine, 35, Shinanomachi, Shinjuku-ku, Tokyo 160-8582, Japan.
Keio University Hospital · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundRecent studies have highlighted the clinical usefulness of near-infrared spectroscopy (NIRS) in psychiatry. However, the potential effects of psychotropics on NIRS signals remain unknown.

methodsWe conducted a systematic chart review of 40 depressed patients who underwent NIRS scans during a verbal fluency task to clarify the relationships between psychotropic dosage and NIRS signals. The dosage of psychotropic medications was calculated using defined daily dose (DDD). We investigated the associations between the DDD of psychotropic medications and oxygenated hemoglobin (oxy-Hb) in single channel levels. LIMITATIONS: Retrospective study design and small sample size are the main limitations.

resultsMultiple regression analysis revealed that one channel in the right temporoparietal region had a significant association with antidepressant DDD controlling for age, sex, depression severity, and the DDD of antipsychotics and benzodiazepines. Moreover, high doses of antidepressants had significant effects on NIRS signals compared with low doses, in group comparisons.

conclusionsThe dose-dependent impact of antidepressants on NIRS signals should be taken into account when interpreting NIRS data.

Indexed as

Spectroscopy, Near-InfraredAdultAntidepressive AgentsCognition DisordersDose-Response Relationship, DrugFemaleHumansMagnetic Resonance ImagingMaleMiddle AgedMood DisordersNerve NetOxyhemoglobinsParietal LobePsychiatric Status Rating ScalesRegression AnalysisAntidepressive AgentsOxyhemoglobinsAnatomical Therapeutic Chemical, (ATC)AntidepressantBipolar disorderdefined daily dose, (DDD)Diagnostic and Statistical Manual of Mental Disorders, (DSM)Hamilton Rating Scale for Depression-17 item, (HRSD-17)International Classification of Diseases, (ICD)magnetic resonance imaging, (MRI)major depressive disorder, (MDD)Major depressive disorder (MDD)Montgomery Asberg Depression Rating Scale, (MADRS)near-infrared spectroscopy, (NIRS)Near-infrared spectroscopy (NIRS)oxy-hemoglobin, (oxy-Hb)positron emission tomography, (PET)regional cerebral blood volume, (rCBV)Schizophreniaverbal fluency task, (VFT)World Health Organization, (WHO)

Identifiers

PMID28348956
PMCPMC5357702
OpenAlexW2588145541

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.